You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Lhasa and Optibrium improve predictive modelling for drug-metabolising enzymes

Optibrium and Lhasa – developers of software and AI solutions for drug discovery and development – have announced the publication of a peer-reviewed study in the Journal of Medicinal Chemistry.